Rhodium’s debts range between $50 million and $100 million, while its total assets are estimated between $100 million and $500 million.

Rhodium, bankruptcy, Bitcoin miningRead More

You might also be interested in reading Outlook Therapeutics® Announces SMC Recommendation of LYTENAVA™ (bevacizumab gamma) for the Treatment of Wet AMD.